Skip to main content
This link has been bookmarked by 1 people . It was first bookmarked on 24 Jul 2011, by avivajazz jazzaviva.
The initial sBCC clearance rate was 90% (12-week post treatment), whereas the proportion of subjects who were clinically clear at 2 years (current time point) was estimated to be 79.4%.
recurrence rate recurrences recurrence-rate BCC sBCC basal-cell-carcinoma basalcellcarcinoma treatment treatments skincancer skin-cancer therapy pubmed pubs trials clinicaltrials abstracts therapies imiquimod aldera aldara study studies
Join Diigo for a free account, or sign in if you are already a member.